Megavec 400 mg (Imatinib Mesylate) in Healthy Adult Male Volunteers
Clinical trial NCT01653314 · COMPLETED
Trial details
- NCT number
- NCT01653314
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2012-03-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.